Influence of common variants in the pharmacokinetic genes (OATP-C, UGT1A1, and MRP2) on serum bilirubin levels in healthy subjects

Hepatology Research

Volumn 30, Issue 2, 2004, Pages 91-95

  Ieiri, Ichiro ^a   Suzuki, Hiroshi ^b   Kimura, Miyuki ^c   Takane, Hiroshi ^a   Nishizato, Yohei ^d   Irie, Shin ^c   Urae, Akinori ^c   Kawabata, Kiyoshi ^e   Higuchi, Shun ^d   Otsubo, Kenji ^a   Sugiyama, Yuichi ^b  

^a TOTTORI UNIVERSITY   (Japan)

^b UNIVERSITY OF TOKYO   (Japan)

^c Kyushu Clinical Pharmacology Research Clinic   (Japan)

^d KYUSHU UNIVERSITY   (Japan)

^e DAIICHI SANKYO CO   (Japan)

Author keywords

Hepatobiliary transport; Organic anion transporter; Polymorphism; Pravastatin

Indexed keywords

BILIRUBIN; GLUCURONOSYLTRANSFERASE 1A1; MULTIDRUG RESISTANCE PROTEIN 2; ORGANIC ANION TRANSPORTER; PRAVASTATIN;

ADULT; AREA UNDER THE CURVE; ARTICLE; BILIRUBIN BLOOD LEVEL; CONTROLLED STUDY; DNA POLYMORPHISM; DRUG BLOOD LEVEL; DRUG CLEARANCE; HUMAN; MALE; NUCLEOTIDE SEQUENCE; PHARMACOGENOMICS; PHENOTYPE; PRIORITY JOURNAL; PROTEIN VARIANT;

EID: 20244380070     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.hepres.2004.07.005     Document Type: Article

References (32)

1. Scharschmidt BF, Waggoner JG, Berk PD. Hepatic organic anion uptake in the rat. J Clin Invest 1975;56:1280-92.
2. Iyanagi T, Emi Y, Ikushiro S. Biochemical molecular aspects of genetic disorders of bilirubin metabolism. Biochim Biophys Acta 1998;1407:173-84.
3. Senafi SB, Clarke DJ, Burchell B. Investigation of the substrate specificity of a cloned expressed human bilirubin UDP-glucuronosyltransferase: UDP-sugar specificity and involvement in steroid and xenobiotic glucuronidation. Biochem J 1994;303:233-40.
4. Jedlitschky G, Leier I, Buchholz U, Hummel-Eisenbeiss J, Burchell B, Keppler D. ATP-dependent transport of bilirubin glucuronides by the multidrug resistance protein MRP1 and its hepatocyte canalicular isoform MRP2. Biochem J 1997;327:305-10.
5. Kamisako T, Leier I, Cui Y, et al. Transport of monoglucuronosyl and bisglucuronosyl bilirubin by recombinant human and rat multidrug resistance protein 2. Hepatology 1999;30:485-90.
6. Mediavilla MG, Pascolo L, Rodriguez JV, Guibert EE, Ostrow JD, Tiribelli C. Uptake of [(3)H]bilirubin in freshly isolated rat hepatocytes: role of free bilirubin concentration. FEBS Lett 1999;463:143-5.
7. Stollman YR, Gartner U, Theilmann L, Ohmi N, Wolkoff AW. Hepatic bilirubin uptake in the isolated perfused rat liver is not facilitated by albumin binding. J Clin Invest 1983;72:718-23.
8. Zucker SD, Goessling W, Hoppin AG. Unconjugated bilirubin exhibits spontaneous diffusion through model lipid bilayers and native hepatocyte membranes. J Biol Chem 1999;274:10852-62.
9. König J, Cui Y, Nies AT, Keppler D. A novel human organic anion transporting polypeptide localized to the basolateral hepatocyte membrane. Am J Physiol 2000;278:G156-64.
10. König J, Cui Y, Nies AT, Keppler D. Localization and genomic organization of a new hepatocellular organic anion transporting polypeptide. J Biol Chem 2000;275:23161-8.
11. Cui Y, König J, Leier I, Buchholz U, Keppler D. Hepatic uptake of bilirubin and its conjugates by the human organic anion transporter SLC21A6. J Biol Chem 2001;276:9626-30.
12. Nishizato Y, Ieiri I, Suzuki H, et al. Polymorphisms of OATP-C (SLC21A6) and OAT3 (SLC22A8) genes: consequences for pravastatin pharmacokinetics. Clin Pharmacol Ther 2003;73:554-65.
13. Ferenci P, Zollner G, Trauner M. Hepatic transport system. J Gastroenterol Hepatol 2002;17(Suppl.):S105-12.
14. Pauli-Magnus C, Meier PJ. Pharmacogenetics of hepatocellular transporters. Pharmacogenetics 2003;13:189-98.
15. Toh S, Wada M, Uchiumi T, et al. Genetic structure of the canalicular multispecific organic anion-transporter gene (MRP2/cMOAT) and mutations in the ATP-binding-cassette region in Dubin-Johnson syndrome. Am J Hum Genet 1999;64:739-46.
16. König J, Nies AT, Cui Y, Leier I, Keppler D. Conjugated export pumps of the multidrug resistance protein (MRP) family: localization, substrate specificity, and MRP2-mediated drug resistance. Biochim Biophys Acta 1999;1461:377-94.
17. Bosnia PJ, Chowdhury JR, Bakker C, et al. The genetic basis of the reduced expression of bilirubin UDP-glucuronosyltransferase 1 in Gilbert's syndrome. N Eng J Med 1995;333:1171-5.
18. Mackenzie PI, Owens IS, Burchell B, et al. The UDP glycosyltransferase gene superfamily: recommended nomenclature update based on evolutionary divergence. Pharmacogenetics 1997;7:255-69.
19. Ito S, Ieiri I, Tanabe M, Suzuki A, Higuchi S, Otsubo K. Polymorphism of the ABC transporter genes, MDR1, MRP2 and MRP2/cMOAT, in healthy Japanese subjects. Pharmacogenetics 2001;11:175-84.
20. Huang CS, Luo GA, Huang MJ, Yu SC, Yang SS. Variations of the bilirubin uridine-diphosphoglucuronosyl transferase 1A1 gene in healthy Taiwanese. Pharmacogenetics 2000;10:539-44.
21. Monaghan G, Ryan M, Seddon R, Hume R, Burchell B. Genetic variation in bilirubin UDP-glucuronosyltransferase gene promoter and Gilbert's syndrome. Lancet 1996;347:578-81.
22. Ritter JK, Chen F, Sheen YY, et al. A novel complex locus UGT1 encodes human bilirubin, phenol, and other UDP-glucuronosyltransferase isozymes with identical carboxyl termini. J Biol Chem 1992;267:3257-61.
23. Mor-Cohen R, Zivelin A, Rosenberg N, Shani M, Muallem S, Seligsohn U. Identification and functional analysis of two novel mutations in the multidrug resistance protein 2 gene in Israeli patients with Dubin-Johnson syndrome. J Biol Chem 2001;276:36923-30.
24. Kullak-Ublick GA. Regulation of organic anion and drug transporters of the sinusoidal membrane. J Hepatol 1999;31:563-73.
25. Meier PJ, Eckhardt U, Schroeder A, Hagenbuch B, Stieger B. Substrate specificity of sinusoidal bile acid and organic anion uptake systems in rat and human liver. Hepatology 1997;26:1667-77.
26. Fevery J. Pathogenesis of Gilbert syndrome. Eur J Clin Invest 1981;11:417-8.
27. Martin JF, Vierling JM, Wolkoff AW, et al. Abnormal hepatic transport of indocyanine green in Gilbert's syndrome. Gastroenterology 1976;70:385-91.
28. Beutler E, Gelbart T, Demina A. Racial variability in the UDP-glucuronosyltransferase 1 (UGT1A1) promoter: a balanced polymorphism for regulation of bilirubin metabolism? Proc Natl Acad Sci USA 1998;95:8170-4.
29. Lampe JW, Bigler J, Horner NK, Potter JD. UDP-glucuronosyltransferase (UGT1A1*28 and UGT1A6*2) polymorphisms in Caucasians and Asians: relationships to serum bilirubin concentrations. Pharmacogenetics 1999;9:341-9.
30. Persico M, Persico E, Bakker CT, et al. Hepatic uptake of organic anions affects the plasma bilirubin level in subjects with Gilbert's syndrome mutations in UGT1A1. Hepatology 2001;33:627-32.
31. Briz O, Serrano MA, Macias RR, Gonzalez-Gallego J, Marin JJG. Role of organic anion-transporting polypeptides, OATP-A, OATP-C and OATP-8, in the human placenta-maternal tandem excretory pathway for foetal bilirubin. Biochem J 2003;371:897-905.
32. Wang P, Kim RB, Chowdhury JR, Wolkoff AW. The human organic anion transport protein SLC21A6 (OATP2) is not sufficient for bilirubin transport. J Biol Chem 2003;278:20695-9.